Stock listing
Viking Therapeutics, Inc.
Selected listing: VKTX · BX · CHF · CH
Viking Therapeutics, Inc. (BX Swiss: VKTX), Health Technology. Latest release Oct 6, 2026: Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance…
- Ticker
- BX Swiss: VKTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BX Swiss
- Currency
- CHF
About Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a public company traded on the American market under the ticker VKTX. Viking Therapeutics focuses on developing innovative therapies for metabolic and endocrine disorders.
Latest news from Viking Therapeutics, Inc.
Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity
October 5, 2026
Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity
October 6, 2026
Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes
September 28, 2026
Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes
September 23, 2026
Viking Therapeutics Announces Positive Topline Results from Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens
September 22, 2026
Events
Research Viking Therapeutics, Inc.
Viking Therapeutics, Inc. company profile
View the public company page for Viking Therapeutics, Inc. on 6ix.
Viking Therapeutics, Inc. news
Read company news and market updates connected to Viking Therapeutics, Inc..
Viking Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Viking Therapeutics, Inc..
Alternate listings
VKTX:NASDAQ
US · USD
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
1VT:GETTEX
DE · EUR
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
A12GD6:LSX
DE · EUR
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
1VT:TRADEGATE
DE · EUR
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
1VT:FWB
DE · EUR
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
A12GD6:LS
DE · EUR
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
1VKTX:MIL
IT · EUR
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
0VQA:LSE
GB · USD
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
VKTX:BOATS
US · USD
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
1VT:SWB
DE · EUR
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
1VT:DUS
DE · EUR
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.
1VT:HAM
DE · EUR
Alternate listing for Viking Therapeutics, Inc.; the primary context on this page is VKTX:BX.